GH
Guardant Health, Inc.
+6.06 (+3.46%)180.96USD642K成交股數24.3B市值–本益比(近四季)20.5股價營收比+44.3%營收年增(近四季)2026-10-28下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 335M+44% | 302M+48% | 281M+47% | 265M+50% | 232M+38% | 203M+31% | 191M+34% | 177M+29% | 168M | 155M | 143M | 137M |
| 營業成本 | 116M | 105M | 99.5M | 93.6M | 81.2M | 74.7M | 74.5M | 72.4M | 65.3M | – | – | – |
| 毛利 | 219M+45% | 197M+53% | 182M+55% | 172M+64% | 151M+46% | 129M | 117M | 105M | 103M | – | – | – |
| 毛利率 | 65.4% | 65.2% | 64.6% | 64.7% | 65.0% | 63.3% | 61.1% | 59.1% | 61.2% | – | – | – |
| 研發費用 | 96.5M | 91.0M | 98.3M | 90.0M | 87.4M | 88.5M | 87.3M | 83.1M | 83.8M | 89.9M | 93.9M | 90.4M |
| 銷售管理費用 | 61.7M | 57.9M | 60.9M | 53.3M | 50.3M | 47.0M | 49.1M | 40.5M | 38.7M | 37.7M | 36.2M | 41.5M |
| 營業利益 | −129M+21% | −121M+9% | −121M+3% | −99.0M-2% | −106M+7% | −111M-44% | −117M+3% | −101M-16% | −99.7M | −198M | −114M | −120M |
| 營業利益率 | -38.5% | -40.2% | -43.0% | -37.3% | -45.9% | -54.6% | -61.3% | -56.8% | -59.2% | -127.4% | -79.4% | -87.2% |
| 稅後淨利 | −120M+20% | −112M+18% | −129M+19% | −92.7M-10% | −99.9M-13% | −95.2M-49% | −108M+25% | −103M+41% | −115M | −187M | −86.1M | −72.8M |
| 淨利率 | -35.9% | -37.2% | -45.7% | -35.0% | -43.0% | -46.8% | -56.3% | -57.9% | -68.2% | -120.6% | -60.2% | -53.1% |
| 稀釋 EPS | -0.90+13% | -0.85+10% | -1.01+15% | -0.74-12% | -0.80-15% | -0.77-51% | -0.88+21% | -0.84+25% | -0.94 | -1.58 | -0.73 | -0.67 |
| 稀釋股數 | 133M | 131M | 125M | 125M | 124M | 124M | 123M | 122M | 122M | 112M | 118M | 109M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 1.1B | 989M | 378M | 580M | 629M | 699M | 585M | 934M | 1.0B | 1.1B | 457M | 271M |
| 應收帳款 | 144M | 137M | 138M | 116M | 130M | 115M | 88.5M | 101M | 84.6M | 88.8M | 88.8M | 86.5M |
| 存貨 | 105M | 83.9M | 85.9M | 90.5M | 84.1M | 77.3M | 72.3M | 67.0M | 63.0M | 61.9M | 77.0M | 60.5M |
| 總資產 | 1.9B | 1.9B | 2.0B | 1.3B | 1.3B | 1.3B | 1.5B | 1.6B | 1.7B | 1.8B | 1.8B | 1.8B |
| 有息負債 | 1.5B | 1.5B | 1.5B | 1.1B | 1.1B | 1.1B | – | – | – | – | – | – |
| 總負債 | 2.1B | 2.1B | 2.1B | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B | 1.5B |
| 股東權益 | −223M | −181M | −99.3M | −354M | −305M | −251M | −60.1M | −1.6M | 68.3M | 159M | 228M | 293M |
| 負債比 | 111.7% | 109.5% | 104.9% | 127.8% | 122.9% | 118.7% | 103.9% | 100.1% | 96.0% | 91.1% | 87.3% | 84.1% |
| 淨現金(現金 − 有息負債) | −449M | −514M | −1.1B | −535M | −486M | −418M | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −65.6M+5% | – | – | – | −62.7M | – | – | −30.3M | – | – | – |
| 資本支出 | – | 5.6M | – | – | – | 4.5M | – | – | 6.9M | – | – | – |
| 自由現金流 | – | −71.2M+6% | – | – | – | −67.1M | – | – | −37.2M | – | – | – |
| 折舊攤銷 | – | 9.4M | – | – | – | 10.2M | – | – | 10.7M | – | – | – |
| 買回庫藏股 | – | 0.00 | – | – | – | 45.0M | – | – | 0.00 | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -23.6% | – | – | – | -33.0% | – | – | -22.1% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 982M
| Reportable | 982M | 100.0% | +32.9% |
|---|
地區2025 年度 · 982M
| 美國 | 923M | 94.0% | +32.4% |
|---|---|---|---|
| 美國以外 | 58.7M | 6.0% | +40.3% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 982M | +32.9% | −416M | -42.4% | -3.32 | −233M |
| FY2024 | 739M | +31.0% | −436M | -59.1% | -3.56 | −275M |
| FY2023 | 564M | +25.5% | −479M | -85.0% | -4.28 | −345M |
| FY2022 | 450M | +20.3% | −655M | -145.6% | -6.41 | −387M |
| FY2021 | 374M | +30.3% | −385M | -103.0% | -4.00 | −284M |
| FY2020 | 287M | +33.8% | −246M | -85.9% | -2.60 | −140M |
| FY2019 | 214M | +136.5% | −75.7M | -35.3% | -0.84 | −65.9M |
| FY2018 | 90.6M | – | −85.1M | -93.8% | -2.80 | −92.4M |